Human E2F6 is alternatively spliced to generate multiple protein isoforms

Biochemical and Biophysical Research Communications

Volumn 317, Issue 3, 2004, Pages 749-760

  Kherrouche, Zoulika ^a   De Launoit, Yvan ^a,b   Monté, Didier ^a  

^a INSTITUT DE BIOLOGIE DE LILLE   (France)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Alternative splicing; E2F6 EMA; Genomic organization; Multiple start sites; Promoter; Repressor

Indexed keywords

GENOMIC DNA; ISOPROTEIN; TRANSCRIPTION FACTOR E2F6;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CHROMOSOME 2; CHROMOSOME 22; CONTROLLED STUDY; EMBRYO; EXON; GC RICH SEQUENCE; GENE; GENE LOCATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOGENE; SEQUENCE ANALYSIS; TATA BOX; TRANSCRIPTION FACTOR E2F6 GENE; TRANSCRIPTION INITIATION SITE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; DNA; E2F6 TRANSCRIPTION FACTOR; EXONS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN CONFORMATION; PROTEIN ISOFORMS; PSEUDOGENES; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 1842790728     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.099     Document Type: Article

References (31)

1. Stevaux O., Dyson N.J. A revised picture of the E2F transcriptional network and RB function. Curr. Opin. Cell Biol. 14:2002;684-691.
2. DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim. Biophys. Acta. 1602:2002;131-150.
3. De Bruin A., Maiti B., Jakoi L., Timmers C., Leone G. Identification and characterization of E2F7, a novel mammalian E2F family member capable of blocking cellular proliferation. J. Biol. Chem. 278:2003;42041-42049.
4. Di Stefano L., Jensen M.R., Helin K. E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes. Embo J. 22:2003;6289-6298.
5. Helin K., Wu C.L., Fattaey A.R., Lees J.A., Dynlacht B.D., Ngwu C., Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1993;1850-1861.
6. Zheng N., Fraenkel E., Pabo C.O., Pavletich N.P. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev. 13:1999;666-674.
7. Muller H., Bracken A.P., Vernell R., Moroni M.C., Christians F., Grassilli E., Prosperini E., Vigo E., Oliner J.D., Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 15:2001;267-285.
8. Ren B., Cam H., Takahashi Y., Volkert T., Terragni J., Young R.A., Dynlacht B.D. E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. Genes Dev. 16:2002;245-256.
9. Ishida S., Huang E., Zuzan H., Spang R., Leone G., West M., Nevins J.R. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol. Cell. Biol. 21:2001;4684-4699.
10. Morkel M., Wenkel J., Bannister A.J., Kouzarides T., Hagemeier C. An E2F-like repressor of transcription. Nature. 390:1997;567-568.
11. Trimarchi J.M., Fairchild B., Verona R., Moberg K., Andon N., Lees J.A. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA. 95:1998;2850-2855.
12. Gaubatz S., Wood J.G., Livingston D.M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA. 95:1998;9190-9195.
13. Trimarchi J.M., Fairchild B., Wen J., Lees J.A. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proc. Natl. Acad. Sci. USA. 98:2001;1519-1524.
14. Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., Nakatani Y. A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells. Science. 296:2002;1132-1136.
15. Cartwright P., Muller H., Wagener C., Holm K., Helin K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene. 17:1998;611-623.
16. Storre J., Elsasser H.P., Fuchs M., Ullmann D., Livingston D.M., Gaubatz S. Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6. EMBO Rep. 3:2002;695-700.
17. Oberley M.J., Inman D.R., Farnham P.J. E2F6 negatively regulates BRCA1 in human cancer cells without methylation of histone H3 on Lysine 9. J. Biol. Chem. 8:2003;8.
18. Kherrouche Z., Begue A., Stehelin D., Monte D. Molecular cloning and characterization of the mouse e2f6 gene. Biochem. Biophys. Res. Commun. 288:2001;22-33.
19. Sharp P.M., Matassi G. Codon usage and genome evolution. Curr. Opin. Genet. Dev. 4:1994;851-860.
20. Modrek B., Lee C. A genomic view of alternative splicing. Nat. Genet. 30:2002;13-19.
21. Mercatante D., Kole R. Modification of alternative splicing pathways as a potential approach to chemotherapy. Pharmacol. Ther. 85:2000;237-243.
22. HumanGenomeProject, Toward a complete human genome sequence, Genome Res. 8 (1998) 1097-1108
23. Burge C.B., Padgett R.A., Sharp P.A. Evolutionary fates and origins of U12-type introns. Mol. Cell. 2:1998;773-785.
24. Kozak M. Adherence to the first-AUG rule when a second AUG codon follows closely upon the first. Proc. Natl. Acad. Sci. USA. 92:1995;2662-2666.
25. Dahme T., Wood J., Livingston D.M., Gaubatz S. Two different E2F6 proteins generated by alternative splicing and internal translation initiation. Eur. J. Biochem. 269:2002;5030-5036.
26. Thanaraj T.A., Clark F., Muilu J. Conservation of human alternative splice events in mouse. Nucleic Acids Res. 31:2003;2544-2552.
27. Modrek B., Lee C.J. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat. Genet. 34:2003;177-180.
28. Lewandowski S., Kalita K., Kaczmarek L. Estrogen receptor beta. Potential functional significance of a variety of mRNA isoforms. FEBS Lett. 524:2002;1-5.
29. Davis P.L., Miron A., Andersen L.M., Iglehart J.D., Marks J.R. Isolation and initial characterization of the BRCA2 promoter. Oncogene. 18:1999;6000-6012.
30. Ince T.A., Scotto K.W. A conserved downstream element defines a new class of RNA polymerase II promoters. J. Biol. Chem. 270:1995;30249-30252.
31. Rudge T.L., Johnson L.F. Inactivation of MED-1 elements in the TATA-less, initiator-less mouse thymidylate synthase promoter has no effect on promoter strength or the complex pattern of transcriptional start sites. J. Cell. Biochem. 73:1999;90-96.